Corina E. Dutcus
Impact in
- Hepatology top 0.5%
- Hepatocellular Carcinoma Treatment and Prognosis
-
- Thyroid Cancer Diagnosis and Treatment
Papers in
-
- Thyroid Cancer Diagnosis and Treatment 35
-
- Renal cell carcinoma treatment 16
- Lung Cancer Treatments and Mutations 10
- Co-authors
- Matthew H. Taylor (36 shared papers)Marcia S. Brose (23 shared papers)Makoto Tahara (25 shared papers)Lori J. Wirth (18 shared papers)Naomi Kiyota (19 shared papers)Andrew G. Gianoukakis (12 shared papers)Steven I. Sherman (15 shared papers)Bruce Robinson (14 shared papers)
- Journals
- Journal of Clinical Oncology (42 papers)Annals of Oncology (20 papers)European Journal of Cancer (7 papers)Future Oncology (3 papers)Gynecologic Oncology (3 papers)
- Partner nations
- United StatesJapanUnited Kingdom
In The Last Decade
Corina E. Dutcus
110 papers receiving 7.5k citations
Corina E. Dutcus's Hit Papers
Peers
Comparison fields: 5 of 97
- Hepatology 1.1k
- Endocrinology, Diabetes and Metabolism 1.8k
- Oncology 2.9k
- Cancer Research 898
- Pulmonary and Respiratory Medicine 1.8k
Countries citing papers authored by Corina E. Dutcus
This map shows the geographic impact of Corina E. Dutcus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Corina E. Dutcus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Corina E. Dutcus more than expected).
Fields of papers citing papers by Corina E. Dutcus
This network shows the impact of papers produced by Corina E. Dutcus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Corina E. Dutcus. The network helps show where Corina E. Dutcus may publish in the future.
Co-authors
The 25 scholars most cited alongside Corina E. Dutcus, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 111 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Lenvatinib versus Placebo in Radioiodine-Refractory Thyroid Cancer Hit paper breakdown → | 2015 | 1474 |
| 2 | Phase Ib Study of Lenvatinib Plus Pembrolizumab in Patients With Unresectable Hepatocellular Carcinoma Hit paper breakdown → | 2020 | 877 |
| 3 | Eribulin monotherapy versus treatment of physician's choice in patients with metastatic breast cancer (EMBRACE): a phase 3 open-label randomised study Hit paper breakdown → | 2011 | 844 |
| 4 | Lenvatinib, everolimus, and the combination in patients with metastatic renal cell carcinoma: a randomised, phase 2, open-label, multicentre trial Hit paper breakdown → | 2015 | 716 |
| 5 | Lenvatinib Plus Pembrolizumab in Patients With Advanced Endometrial Cancer Hit paper breakdown → | 2020 | 369 |
| 6 | Lenvatinib plus pembrolizumab in patients with advanced endometrial cancer: an interim analysis of a multicentre, open-label, single-arm, phase 2 trial Hit paper breakdown → | 2019 | 368 |
| 7 | 2015 | 343 | |
| 8 | Phase IB/II Trial of Lenvatinib Plus Pembrolizumab in Patients With Advanced Renal Cell Carcinoma, Endometrial Cancer, and Other Selected Advanced Solid Tumors Hit paper breakdown → | 2020 | 315 |
| 9 | 2017 | 151 | |
| 10 | 2019 | 102 | |
| 11 | 2019 | 93 | |
| 12 | 2019 | 88 | |
| 13 | 2017 | 86 | |
| 14 | 2018 | 84 | |
| 15 | 2018 | 84 | |
| 16 | 2020 | 77 | |
| 17 | 2018 | 71 | |
| 18 | 2016 | 70 | |
| 19 | 2017 | 66 | |
| 20 | 2017 | 66 |
About Corina E. Dutcus
Corina E. Dutcus is a scholar working on Endocrinology, Diabetes and Metabolism, Pulmonary and Respiratory Medicine, Oncology, Molecular Biology and Hepatology, having authored 111 papers that have together received 7.7k indexed citations. Recurring topics across this work include Thyroid Cancer Diagnosis and Treatment (35 papers), Hepatocellular Carcinoma Treatment and Prognosis (17 papers), Renal cell carcinoma treatment (16 papers), Cancer Immunotherapy and Biomarkers (15 papers), Endometrial and Cervical Cancer Treatments (11 papers), Lung Cancer Treatments and Mutations (10 papers), Radiopharmaceutical Chemistry and Applications (9 papers) and Cancer Treatment and Pharmacology (8 papers). The work is most often cited by research in Hepatology (1.1k citations), Endocrinology, Diabetes and Metabolism (1.8k citations), Oncology (2.9k citations), Cancer Research (898 citations) and Pulmonary and Respiratory Medicine (1.8k citations). Corina E. Dutcus has collaborated with scholars based in United States, Japan and United Kingdom. Frequent co-authors include Matthew H. Taylor, Marcia S. Brose, Makoto Tahara, Lori J. Wirth, Naomi Kiyota, Andrew G. Gianoukakis, Steven I. Sherman, Bruce Robinson, Martin Schlumberger and Mouhammed Amir Habra. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, European Journal of Cancer, Future Oncology and Gynecologic Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.